Cost-effectiveness Study of the CIPA Screening Method for Patients With Nutritional Risk at Hospital Admission
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 823
- 试验地点
- 2
- 主要终点
- Cost-effectiveness measured by incremental Cost-effectiveness ratio (ICER)
研究概览
简要总结
Objectives: To evaluate the cost-effectiveness of implementing a malnutrition screening tool "CIPA" at the Hospital Universitario Nuestra Señora de la Candelaria (HUNSC), comparing the impact on health and the healthcare costs of hospitalised patients who are screened for malnutrition and of patients following standard clinical practice. Methodology: The study will consist of a controlled trial on patients admitted to the Internal Medicine and General and Digestive Surgery wards at the HUNSC. In both wards patients will be assigned to a control or to an intervention group. The control group will follow usual hospital clinical care, while the intervention group will be administered the screening tool "CIPA" for early detection of malnutrition cases and they will be treated according to the screening results. The following variables will be evaluated: length of stay in hospital, mortality, readmissions and in-hospital complications. Cost-effectiveness analysis will be undertaken measuring effectiveness by Quality-Adjusted Life Years (QALYs). Cost per patient will be measured by identifying health care resource utilisation, and the cost-effectiveness measure will be the Incremental Cost-Effectiveness Ratio (ICER). Investigators will calculate the incremental cost per QALY gained related to the intervention. This analysis will allow to quantify the costs (incurred and saved) related to the introduction of the malnutrition screening tool CIPA in the hospital context and to measure the health impact of screened patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Formal consent to participate in the study.
- •Patients admitted to the Internal Medicine or General Surgery wards.
排除标准
- •Patients treated with nutritional support before CIPA screening is performed.
- •Patients transferred from other wards.
- •Patients with an expected length of stay less than 72 hours.
- •CIPA screening unfeasible for any reason.
- •Patients with poor short-term prognosis.
- •Bed destination at hospital admission nonrandomized.
- •Patients participating in other investigation study.
- •Pregnancy
研究组 & 干预措施
CIPA screening tool
Patients are evaluated by CIPA nutritional screening tool
干预措施: CIPA nutritional screening tool (Other)
usual hospital clinical care
Patients are not subject of CIPA screening tool, and continue the usual hospital clinical care
结局指标
主要结局
Cost-effectiveness measured by incremental Cost-effectiveness ratio (ICER)
时间窗: up to 3 months after Hospital discharge time
次要结局
- incidence of readmissions(up to 3 months after hospital discharge time)
- Quality of life measured by quality-adjusted life years (QALYs)(up to 3 months after Hospital discharge time)
- mean length of stay (days)(through study completion, an average of 13 days)
- incidence of mortality(up to 3 months after Hospital discharge time)
研究者
José Pablo Suárez Llanos
Ph.D, M.D.
University Hospital of the Nuestra Señora de Candelaria
